(Q36562331)

14 August 2017

Morphometric analysis of immunoselection against hyperploid cancer cells (English)

1 reference

14 August 2017

10

Laura Senovilla

0 references

Guido Kroemer

9

Guido Kroemer

0 references

Oliver Kepp

8

Oliver Kepp

0 references

Aitziber Buqué

4

José Manuel Bravo-San Pedro

Aitziber Buqué

0 references

José Manuel Bravo-San Pedro

6

0 references

Norma Bloy

1

Norma Bloy

1 reference

14 August 2017

5

Juliette Humeau

1 reference

14 August 2017

Allan Sauvat

2

1 reference

14 August 2017

Kariman Chaba

3

1 reference

14 August 2017

Jack Bui

7

1 reference

14 August 2017

language of work or name

English

0 references

publication date

15 October 2015

1 reference

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

38

1 reference

14 August 2017

41204-41215

1 reference

eIF2α phosphorylation as a biomarker of immunogenic cell death

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Pan-cancer patterns of somatic copy number alteration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Immunosurveillance against tetraploidization-induced colon tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

An immunosurveillance mechanism controls cancer cell ploidy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Cancer immunoediting by the innate immune system in the absence of adaptive immunity.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Causes and consequences of aneuploidy in cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Cytofluorometric purification of diploid and tetraploid cancer cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Natural innate and adaptive immunity to cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Illicit survival of cancer cells during polyploidization and depolyploidization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Tumor cell metabolism: cancer's Achilles' heel

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Ecto-calreticulin in immunogenic chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Cancer despite immunosurveillance: immunoselection and immunosubversion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Apoptosis regulation in tetraploid cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

30 September 2017

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Breaking through the central tolerance ceiling to unleash anticancer immune responses.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Cytofluorometric assessment of cell cycle progression

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Adaptive immunity maintains occult cancer in an equilibrium state

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4747400

Decoding cell death signals in inflammation and immunity

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26517677

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.5400

1 reference

release_ookungatffeftgsz5pqbr22m2y

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ookungatffeftgsz5pqbr22m2y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 August 2017

1 reference